Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Schizophrenia is a complex and challenging condition that significantly impacts patients’ lives. Traditional clinical trial designs often fail to capture the full spectrum of patient experiences and outcomes. By incorporating patient insights, we can develop more patient-centric trials that improve recruitment and retention and ensure that the outcomes measured are meaningful to those living with the condition.
Join us for an insightful webinar that delves into the critical role of patient insights in optimizing clinical trial design and outcome measures for schizophrenia studies. Moderated by Dr. Mohit Verma, global therapeutic area head of psychiatry at Parexel, this session will feature leading experts from Parexel’s feasibility and clinical operations teams.
Key Topics:
- Changing regulatory landscape: Insights into recent interactions with regulatory agencies and implications for advancing novel therapies.
- Patient insights in trial design: Best practices for engaging patients and caregivers to inform protocol design, eligibility criteria, and recruitment/retention strategies.
- Innovative outcome measures: Development and validation of patient-reported outcomes and other endpoints, including new digital tools for assessing cognitive impairment.
- Future directions: Impact of global events on trial recruitment, precision medicine approaches, and strategies for reaching targeted patient populations.
Speakers:
Moderator: Mohit Verma, M.D., Global Therapeutic Area Head, Psychiatry, Parexel
Panelists:
- Jaime Roberts, Associate Director, Feasibility Strategy, Parexel
Who Should Attend: This webinar is essential for sponsors, researchers, regulators, and drug developers working on innovative therapies for schizophrenia. Gain expert perspectives on navigating the complex landscape of schizophrenia clinical trials and drug development.
Related Insights
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
CTB Blog
The essential role of translation in early phase neurology research
Jun 18, 2026
Video
Bench-to-bedside: Transforming scientific breakthroughs into clinical success
Apr 3, 2026
Blog
Do we still need broad patient representation in breast cancer trials? Absolutely.
Oct 17, 2025
Webinar
Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
May 15, 2025
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 28, 2024
Blog
Parkinson’s Disease Patient Advocacy Q&A
Sep 18, 2024
Webinar
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives
Aug 22, 2024
Related Insights
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
CTB Blog
The essential role of translation in early phase neurology research
Jun 18, 2026
Video
Bench-to-bedside: Transforming scientific breakthroughs into clinical success
Apr 3, 2026
Blog
Do we still need broad patient representation in breast cancer trials? Absolutely.
Oct 17, 2025
Webinar
Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
May 15, 2025
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 28, 2024
Blog
Parkinson’s Disease Patient Advocacy Q&A
Sep 18, 2024
Webinar
Alzheimer’s Disease vs Multiple Sclerosis Drug Development: Similarities, Differences & New Perspectives
Aug 22, 2024